40y.o.≥ 200mg/dL≥20%3%Tyrer-Cuzickmodeloverweight/ obesity75y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorspneumococcalq1ymammogramGailmodelbreastcancerraloxifenestatinaromataseinhibitorscommunity-dwelling,postmenopausalwomencolorectalcancertamoxifen40-59 y.o.,ASCVD ≥10%, lowbleeding risk50y.o.hormonetherapyinsufficientevidenceforscreeninghypertension≥ 100mg/dL≤q2y< 60y.o.60y.o.q15y65y.o.multidoseinitial series,then 1 doseat 2-6monthsherpeszosterlungcancerPREVENTequation≥5.7%HepatitisC40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factordementiaq5ycervicalcancerq1yq1-2ymammogrambased on lifeexpectancy /health status≥ 126mg/dLq3y40-70 y.o.,ASCVD ≥10%, lowbleeding risk1 dose; 2doses (2-6monthsapart) ifimmunocomp≥ 140mg/dLtobaccouseovariancancerFractureRiskAssessmentTool2 doses,2-6monthsapartdyslipidemiaaspirin40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorHIV52y.o.cardiovasculardisease40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsTimedup andgo testHepatitisBwomenage 55-64 y.o.diabetesdepressionq2yanxiety≥6.5%40y.o.≥ 200mg/dL≥20%3%Tyrer-Cuzickmodeloverweight/ obesity75y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorspneumococcalq1ymammogramGailmodelbreastcancerraloxifenestatinaromataseinhibitorscommunity-dwelling,postmenopausalwomencolorectalcancertamoxifen40-59 y.o.,ASCVD ≥10%, lowbleeding risk50y.o.hormonetherapyinsufficientevidenceforscreeninghypertension≥ 100mg/dL≤q2y< 60y.o.60y.o.q15y65y.o.multidoseinitial series,then 1 doseat 2-6monthsherpeszosterlungcancerPREVENTequation≥5.7%HepatitisC40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factordementiaq5ycervicalcancerq1yq1-2ymammogrambased on lifeexpectancy /health status≥ 126mg/dLq3y40-70 y.o.,ASCVD ≥10%, lowbleeding risk1 dose; 2doses (2-6monthsapart) ifimmunocomp≥ 140mg/dLtobaccouseovariancancerFractureRiskAssessmentTool2 doses,2-6monthsapartdyslipidemiaaspirin40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorHIV52y.o.cardiovasculardisease40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsTimedup andgo testHepatitisBwomenage 55-64 y.o.diabetesdepressionq2yanxiety≥6.5%

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. 40 y.o.
  2. ≥ 200 mg/dL
  3. ≥ 20%
  4. 3%
  5. Tyrer-Cuzick model
  6. overweight / obesity
  7. 75 y.o.
  8. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  9. pneumococcal
  10. q1y mammogram
  11. Gail model
  12. breast cancer
  13. raloxifene
  14. statin
  15. aromatase inhibitors
  16. community-dwelling, postmenopausal women
  17. colorectal cancer
  18. tamoxifen
  19. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  20. 50 y.o.
  21. hormone therapy
  22. insufficient evidence for screening
  23. hypertension
  24. ≥ 100 mg/dL
  25. ≤ q2y
  26. < 60 y.o.
  27. 60 y.o.
  28. q15y
  29. 65 y.o.
  30. multidose initial series, then 1 dose at 2-6 months
  31. herpes zoster
  32. lung cancer
  33. PREVENT equation
  34. ≥ 5.7%
  35. Hepatitis C
  36. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  37. dementia
  38. q5y
  39. cervical cancer
  40. q1y
  41. q1-2y mammogram based on life expectancy / health status
  42. ≥ 126 mg/dL
  43. q3y
  44. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  45. 1 dose; 2 doses (2-6 months apart) if immunocomp
  46. ≥ 140 mg/dL
  47. tobacco use
  48. ovarian cancer
  49. Fracture Risk Assessment Tool
  50. 2 doses, 2-6 months apart
  51. dyslipidemia
  52. aspirin
  53. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  54. HIV
  55. 52 y.o.
  56. cardiovascular disease
  57. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  58. Timed up and go test
  59. Hepatitis B
  60. women age 55-64 y.o.
  61. diabetes
  62. depression
  63. q2y
  64. anxiety
  65. ≥ 6.5%